| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
3 companies
Broadwood Partners, L.P. is a Director, 10% Owner at LCTX with holdings across 3 companies. Recent SEC Form 4 filings include 12 buys and 26 sells.
Estimated insider holdings value: $586.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2021 | STAA Staar Surgical Co | 10% Owner | Sell | 37,451 | $124.42 | $4,659,609.22 | - | |
| Feb 9, 2021 | STAA Staar Surgical Co | 10% Owner | Sell | 257,619 | $121.59 | $31,324,184.93 | -0.4% | |
| Feb 5, 2021 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 600,000 | $4.50 | $2,700,000.00 | +1.8% | |
| Feb 4, 2021 | STAA Staar Surgical Co | 10% Owner | Sell | 60,861 | $111.00 | $6,755,865.93 | -0.1% | |
| Jan 28, 2021 | STAA Staar Surgical Co | 10% Owner | Sell | 789,883 | $103.91 | $82,075,795.65 | -1.3% | |
| Jan 20, 2021 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,460,280 | $3.42 | $4,999,998.72 | +4.7% | |
| Jan 12, 2021 | STAA Staar Surgical Co | 10% Owner | Sell | 60,000 | $89.28 | $5,356,800.00 | -0.3% | |
| Apr 24, 2020 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,050,000 | $2.27 | $2,383,500.00 | +3.7% | |
| Jan 2, 2020 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,391,466 | $2.16 | $3,000,000.70 | +2.7% | |
| Nov 13, 2019 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,176,471 | $1.70 | $2,000,000.70 | +5.0% |